Antinociceptive effects of the essential oil of Alpinia zerumbet on mice
Alpinia zerumbet (Pers.) Burtt. et Smith is an aromatic plant that is distributed widely in the tropical and sub-tropical regions of the world. In Brazil, where A. zerumbet is called “colonia”, it is used widely in folk medicine for the treatment of various diseases, including hypertension. In the p...
Gespeichert in:
Veröffentlicht in: | Phytomedicine (Stuttgart) 2005-06, Vol.12 (6), p.482-486 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Alpinia zerumbet (Pers.) Burtt. et Smith is an aromatic plant that is distributed widely in the tropical and sub-tropical regions of the world. In Brazil, where
A. zerumbet is called “colonia”, it is used widely in folk medicine for the treatment of various diseases, including hypertension. In the present study, the antinociceptive effects of the orally administered essential oil of
A. zerumbet (EOAz) were evaluated in male Swiss mice (20–25
g each). In the acetic acid-induced writhing test, EOAz (30, 100 and 300
mg/kg
body
wt.;
n
=
10
,
n
=
13
and
n
=
15
, respectively) was effective at all doses. In the hot-plate test, EOAz significantly increased the latency at doses of 100 and 300
mg/kg
body
wt., but not at 30
mg/kg
body
wt., at all observation times up to the 180th min (
n
=
10
for each dose). In the formalin test, EOAz significantly reduced paw licking time in the second phase of the test at 100
mg/kg
body
wt. (
n
=
10
), but decreased it in both phases at 300
mg/kg
body
wt. (
n
=
10
). At 30
mg/kg
body
wt., the effect of EOAz did not differ from control values in either phase of the formalin test (
n
=
10
). Pretreatment with naloxone (5
mg/kg
body
wt., i.p.) caused a significant reversal of the analgesic effect of 300
mg/kg
body
wt. EOAz (
n
=
8
) that was complete for the first phase, but only partial for the second phase of the formalin test. The data show that orally administered OEAz promotes a dose-dependent antinociceptive effect, with a mechanism of action which probably involves the participation of opiate receptors. |
---|---|
ISSN: | 0944-7113 1618-095X |
DOI: | 10.1016/j.phymed.2004.04.006 |